Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of Nasal Glucagon in Diabetes
NCT01959334Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Sep 2013
- Primary completion
- Dec 2013
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of glucagon in hypoglycemia, sponsored by Eli Lilly and Company. Started Sep 2013; status: completed.
02
Drugs
glucagon
03
Conditions
hypoglycemia
Beyond the preview
Go deeper on NCT01959334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01959334.